Pharmaceutical composition, containing a beta-3-adrenoceptor agonist and an alpha antagonist and/or a 5-alpha-reductase inhibitor

Details for Australian Patent Application No. 2004285289 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Ebinger, Ursula; Michel, Martin; Wienrich, Marion

Agent Davies Collison Cave

Pub. Number AU-A-2004285289

PCT Pub. Number WO2005/042021

Priority 10352131.3 04.11.03 DE; 10351539.9 03.11.03 DE

Filing date 29 October 2004

Wipo publication date 12 May 2005

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/215 (2006.01)

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/042021 Priority application(s): WO2005/042021

27 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004285293-Method for coating implants by way of a printing method

2004285284-A process for the preparation of an active-ingredient-containing formulation with a coating